Avita Medical

Avita Medical Limited manufactures the medical device, ReCell, a ‘spray on skin’ device used to treat serious burns. ReCell is CE-approved for use in Europe, with FDA approval anticipated mid 2018 for the USA market.

Curious PR is provided social media content and activation, plus media relations activity, to ensure that news concerning a recent, multi-centre, randomised controlled trial involving ReCell reached key members of the media, and that its significance was understood by medical and consumer audiences, alike. Coverage was secured in The Daily Mail’s influential ‘Good Health’ section, as well as in Nursing Times.